The hypoxic tumour microenvironment and metastatic progression
暂无分享,去创建一个
[1] P. Friedl,et al. The biology of cell locomotion within three-dimensional extracellular matrix , 2000, Cellular and Molecular Life Sciences CMLS.
[2] I. Fidler,et al. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] J. Norgauer,et al. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. , 1996, Journal of immunology.
[4] M. Horsman,et al. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review. , 1995, Acta oncologica.
[5] D. Schadendorf,et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.
[6] R. Airley,et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] J. Vaage. A survey of in vivo growth characteristics and spontaneous metastasizing potentials of C3H mouse mammary tumors , 1989, International journal of cancer.
[8] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[9] R. Hill,et al. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. , 1990, Journal of the National Cancer Institute.
[10] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[11] A. Harris,et al. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling , 2000, Oncogene.
[12] H. Lyng,et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. , 1997, The American journal of pathology.
[13] T. Curran,et al. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. , 1994, Molecular and cellular biology.
[14] J. Purdy,et al. Quality assurance for 3D conformal radiation therapy. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[15] Berk,et al. Scale-invariant behavior and vascular network formation in normal and tumor tissue. , 1995, Physical review letters.
[16] G. Semenza,et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. , 2001, Cancer research.
[17] E. Rofstad,et al. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8 , 2002, British Journal of Cancer.
[18] L. Liotta,et al. General mechanisms of metastasis , 1997, Cancer.
[19] S. Eccles,et al. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis , 2001, Cancer.
[20] Michael I. Wilson,et al. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.
[21] Ji Huang,et al. [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.
[22] A. Al-Mehdi,et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.
[23] O. Hankinson,et al. Identification of genes differentially induced by hypoxia in pancreatic cancer cells. , 2001, Biochemical and biophysical research communications.
[24] J. Slavin,et al. Fibroblast growth factors: at the heart of angiogenesis. , 1995, Cell biology international.
[25] T. Graeber,et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.
[26] A. Harris,et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.
[27] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[28] M. Gassmann,et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.
[29] R. Hill. Tumor progression: Potential role of unstable genomic changes , 1990, Cancer and Metastasis Reviews.
[30] A. Harris,et al. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. , 1997, Cancer research.
[31] E. Rofstad,et al. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. , 2002, Cancer research.
[32] L. Poellinger,et al. Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. , 2002, Blood.
[33] C. Rinker-Schaeffer,et al. Metastasis-suppressor genes: a review and perspective on an emerging field. , 2000, Journal of the National Cancer Institute.
[34] U. Staedt,et al. Substrate balances across colonic carcinomas in humans. , 1995, Cancer research.
[35] Eamonn R. Maher,et al. Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* , 2000, The Journal of Biological Chemistry.
[36] R. Cardiff,et al. Mammary epithelial-specific expression of the integrin linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice , 2001, Oncogene.
[37] I. Nabi,et al. Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells. , 2000, Biochemical and biophysical research communications.
[38] Erwin G. Van Meir. Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. , 1996, Neurosurgery.
[39] R. Pötter,et al. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] A. Harris,et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. , 2001, Cancer research.
[41] H. Lyng,et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis , 2000, British Journal of Cancer.
[42] A. Harris,et al. The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer , 2002, British Journal of Cancer.
[43] Alan Cantor,et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. , 2002, Journal of the National Cancer Institute.
[44] L. Ellis,et al. Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice , 2004, Clinical & Experimental Metastasis.
[45] S. Dedhar,et al. The integrin-linked kinase (ILK) suppresses anoikis , 2000, Oncogene.
[46] M. Dewhirst,et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.
[47] Y. Zou,et al. Nuclear Factor Interleukin 6 Motifs Mediate Tissue-specific Gene Transcription in Hypoxia* , 1997, The Journal of Biological Chemistry.
[48] S. Frisch,et al. Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.
[49] E. Rofstad,et al. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. , 2000, Cancer research.
[50] A. Harris,et al. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[51] E. Rofstad,et al. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. , 1995, Cancer research.
[52] D A Hilton,et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.
[53] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[54] K. Matsushima,et al. Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[55] T. Kawamoto,et al. Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. , 1997, Biochemical and biophysical research communications.
[56] W. Birchmeier,et al. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.
[57] A. Hartmann,et al. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. , 1999, Cancer research.
[58] K. Webster,et al. Hypoxia Regulates β-Enolase and Pyruvate Kinase-M Promoters by Modulating Sp1/Sp3 Binding to a Conserved GC Element* , 1998, The Journal of Biological Chemistry.
[59] L. Ellis,et al. The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.
[60] T. E. Fitzpatrick,et al. Effect of hypoxia on cellular adhesion to vitronectin and fibronectin. , 2001, Biochemical and biophysical research communications.
[61] T. Kawamoto,et al. Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway. , 2001, European journal of cell biology.
[62] A. Koong,et al. Epigenetic Regulation of Gene Expression in Cervical Cancer Cells by the Tumor Microenvironment 1 , 2000 .
[63] C. Graham,et al. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. , 2001, Experimental cell research.
[64] P. Ratcliffe,et al. Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.
[65] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[66] T. Veikkola,et al. Regulation of angiogenesis via vascular endothelial growth factor receptors. , 2000, Cancer research.
[67] S. Fox,et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[68] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[69] D. Hedley,et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] D. Peet,et al. Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.
[71] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[72] Y. S. Kim,et al. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. , 2001, Cancer research.
[73] M. Schindl,et al. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.
[74] P. Glazer,et al. Genetic instability induced by the tumor microenvironment. , 1996, Cancer research.
[75] G. Semenza,et al. Molecular basis of hypoxia‐induced erythropoietin expression , 1996, Current opinion in hematology.
[76] Y. Zou,et al. Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.
[77] E. Rofstad,et al. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. , 2002, Cancer research.
[78] H. Lyng,et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[79] K. Luzzi,et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.
[80] A. Fyles,et al. Interstitial Fluid Pressure in Cervical Cancer: Guide to Targeted Therapy , 2001, American journal of clinical oncology.
[81] T. Danielsen,et al. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis , 1999, British Journal of Cancer.
[82] Napoleone Ferrara,et al. Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.
[83] J. Winstanley,et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. , 2002, Cancer research.
[84] A. Hartmann,et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. , 1999, The American journal of pathology.
[85] M. Dewhirst,et al. Concepts of oxygen transport at the microcirculatory level. , 1998, Seminars in radiation oncology.
[86] L. Liotta,et al. Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration , 1987, Nature.
[87] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[88] M Hubank,et al. Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.
[89] F. Howe,et al. Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.
[90] G. Semenza,et al. HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.
[91] E. Rofstad,et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. , 2000, Cancer research.
[92] A. Harris,et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[93] M. Bar‐eli. Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma , 1999, Pathobiology.
[94] R. Strausberg,et al. Transcriptional response to hypoxia in human tumors. , 2001, Journal of the National Cancer Institute.
[95] O. S. Nielsen,et al. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations , 2001, British Journal of Cancer.
[96] L. Liotta,et al. Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: Human melanoma and ras‐transfected NIH3T3 cells , 1991, International journal of cancer.
[97] I. Tannock,et al. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. , 1998, British Journal of Cancer.
[98] A. Maity,et al. Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia. , 2000, Experimental cell research.
[99] J. Overgaard,et al. Techniques to assess the oxygenation of human tumors. State of the art. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[100] R. Khokha,et al. Anoikis and metastatic potential of cloudman S91 melanoma cells. , 2001, Cancer research.
[101] K. Webster,et al. Physical and functional sensitivity of zinc finger transcription factors to redox change , 1996, Molecular and cellular biology.
[102] J. Marshall,et al. Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability. , 1998, British Journal of Cancer.
[103] G. Semenza,et al. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.
[104] D. Schatz,et al. cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. , 1999, Methods in enzymology.
[105] Michael V. Doyle,et al. Regulation of Integrin Function by the Urokinase Receptor , 1996, Science.
[106] P. Okunieff,et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. , 1989, Cancer research.
[107] A. Koong,et al. Candidate genes for the hypoxic tumor phenotype. , 2000, Cancer research.
[108] R. Khokha,et al. Steps in tumor metastasis: new concepts from intravital videomicroscopy , 1995, Cancer and Metastasis Reviews.
[109] R. Hill,et al. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[110] N. Brünner,et al. Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[111] T Shinozaki,et al. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.
[112] A. Koong,et al. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. , 1994, Cancer research.
[113] M. Lerman,et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.
[114] S. Macdonald-Goodfellow,et al. Hypoxia‐mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression , 1999, International journal of cancer.
[115] T. E. Fitzpatrick,et al. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. , 1998, Blood.
[116] J. Overgaard,et al. Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers. , 1996, Seminars in radiation oncology.
[117] P. Andreasen,et al. The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.
[118] H. Birnboim,et al. Mutagenicity and cytotoxicity of reactive oxygen and nitrogen species in the MN-11 murine tumor cell line. , 1997, Mutation research.
[119] S. De Flora,et al. ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[120] M. W. D. Dvm. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome , 1998 .
[121] C. Dinney,et al. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. , 2000, Cancer research.
[122] G. Semenza,et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.
[123] J. Alam,et al. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. , 2001, International journal of oncology.
[124] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[125] R. Hill,et al. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells , 1997, Clinical & Experimental Metastasis.
[126] L. Ellis,et al. Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. , 2001, Cancer biotherapy & radiopharmaceuticals.
[127] A Dietz,et al. Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[128] G. Semenza,et al. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.
[129] C. Bucana,et al. Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity. , 2000, Cytokines, cellular & molecular therapy.
[130] R. Hill,et al. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.
[131] I. Tannock,et al. Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[132] J. Isaacs,et al. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. , 1997, Cancer research.
[133] M Molls,et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.